The U.S. Food and Drug Administration renewed the modified‑risk tobacco product (MRTP) orders for Philip Morris International’s IQOS devices and three HEETS consumable variants on April 17, 2026. The renewal allows PMI to continue making reduced‑exposure claims to U.S. adults 21 and older who use traditional cigarettes, a marketing advantage that competitors cannot legally claim.
The renewed orders cover two IQOS device systems and the three HEETS variants—Marlboro Amber HeatSticks, Marlboro Green Menthol HeatSticks, and Marlboro Blue Menthol HeatSticks—ensuring that the full range of PMI’s heated‑tobacco offerings remains eligible for reduced‑exposure messaging.
By maintaining MRTP status, PMI safeguards its high‑margin smoke‑free business and reinforces its broader transformation strategy toward a smoke‑free platform. The ability to communicate reduced‑exposure benefits differentiates IQOS from combustible cigarettes and supports PMI’s goal of shifting adult smokers away from traditional products.
PMI has invested more than $16 billion globally since 2008 to develop and commercialize smoke‑free products, which accounted for 41.5 % of its total net revenues in 2025. The renewal confirms that the company’s substantial investment is translating into a growing, regulated revenue stream that can sustain its long‑term growth trajectory.
PMI is the only company with MRTP authorizations for heated tobacco products in the United States, positioning it as the market leader in this segment. The FDA’s decision is based on scientific evidence that switching entirely to IQOS significantly reduces exposure to harmful chemicals, while the agency emphasizes that the designation does not imply safety or FDA approval. The renewal is subject to ongoing regulatory oversight and post‑market surveillance.
Analysts continue to view PMI’s smoke‑free strategy favorably, noting that the company’s regulatory advantage and investment in product innovation underpin its competitive edge in a rapidly evolving market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.